标普生物科技LOF(161127)
动态评分: 4.62分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2018-12-31 | PGEN | Precigen Inc | 68.59 | 0.57% |
2018-12-31 | VCEL | Vericel Corp | 67.82 | 0.56% |
2018-12-31 | BOLD | Audentes Therapeutics Inc | 66.3 | 0.55% |
2018-12-31 | CARA | Cara Therapeutics Inc | 62.54 | 0.52% |
2018-12-31 | BHVN | Biohaven Pharmaceutical Holding Co Ltd | 58.91 | 0.49% |
2018-12-31 | XNCR | Xencor Inc | 57.01 | 0.47% |
2018-12-31 | ALDR | Alder BioPharmaceuticals Inc | 55.42 | 0.46% |
2018-12-31 | FLXN | Flexion Therapeutics Inc | 54.93 | 0.45% |
2018-12-31 | MNTA | Momenta Pharmaceuticals Inc | 53.72 | 0.44% |
2018-12-31 | DVAX | 德纳维制药 | 51.08 | 0.42% |
2018-12-31 | CHRS | Coherus BioSciences Inc | 49.32 | 0.41% |
2018-12-31 | GTHX | G1 Therapeutics Inc | 48.38 | 0.4% |
2018-12-31 | KPTI | Karyopharm Therapeutics Inc | 45.73 | 0.38% |
2018-12-31 | TVTX | Travere Therapeutics Inc | 45.83 | 0.38% |
2018-12-31 | SLDB | Solid Biosciences Inc | 43.17 | 0.36% |
2018-12-31 | NVAX | 诺瓦瓦克斯医药 | 42.14 | 0.35% |
2018-12-31 | TGTX | TG Therapeutics Inc | 41.93 | 0.35% |
2018-12-31 | PGNX | 普罗基尼克斯制药 | 40.9 | 0.34% |
2018-12-31 | DRNA | Dicerna Pharmaceuticals Inc | 39.51 | 0.33% |
2018-12-31 | DNLI | Denali Therapeutics Inc | 39.02 | 0.32% |
公告&资料
